NASDAQ: BIIB - Biogen

Yield per half year: -31%
Dividend yield: 0.00%
Sector: Healthcare

Current price
148.82 $
Average price
86.44 $ -41.92%

Average analyst price
241.7 $ +62.41%
Price based on EPS
70 $ -52.96%
Price according to DCF model (ebitda)
71.2 $ -52.16%
2/10

Average analyst price

Fair price = 241.7 $
Current price = 148.82 $ (difference = +62.41%)

Idea Price forecast Changes Expiration date Analyst
Biogen: возьмем на память 241.7 $ +92.88 $ (62.41%) 11.09.2025 Финам

Price based on EPS

Price = EPS * (1 + CAGR EPS) / (Key Rate * Excess Key Rate)
Key Rate = Key rate
Fair price = 70 $
Current price = 148.82 $ (difference = -52.96%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 71.2 $
Current price = 148.82 $ (difference = -52.16%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 26.19 $
Current price = 148.82 $ (difference = -82.4%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription